Parabellum Investments-sponsored Advanco, which develops pharmaceutical-packaging software, could acquire as part of plans to grow two- or threefold over the coming years, Parabellum founder and CEO Rami Cassis told Mergermarket.
The Belgium-headquartered company generates around EUR 4M revenue with 30% profit margins, Cassis said. It is looking for several targets complementary to its software suite, which uses serialisation to ensure pharmaceutical goods are traceable along their supply chain, he said.
It may look at software companies that provide an enterprise level of visibility over a whole pharmaceutical supply chain, from manufacturing and distribution, he said. This would complement Advanco’s existing software, which is designed for factory-level pharmaceutical manufacturing.
Continue reading: https://www.mergermarket.com/intelligence/view/3019271